Genome stability-related lncRNA ZFPM2-AS1 promotes tumor progression via miR-3065-5p/XRCC4 in hepatocellular carcinoma

被引:3
作者
Liu, Jie [1 ,2 ]
Zhang, Hao [1 ,2 ]
Xia, Peng [1 ,2 ]
Zhu, Yimin [1 ,2 ]
Xu, Kequan [1 ,2 ]
Liu, Zhisu [1 ,2 ,3 ]
Yuan, Yufeng [1 ,2 ,3 ]
机构
[1] Wuhan Univ, Zhongnan Hosp, Dept Hepatobiliary & Pancreat Surg, Wuhan 430071, Hubei, Peoples R China
[2] Clin Med Res Ctr Minimally Invas Procedure Hepatob, Wuhan 430071, Hubei, Peoples R China
[3] Wuhan Univ, Zhongnan Hosp, Dept Hepatobiliary & Pancreat Surg, 169 Donghu Rd, Wuhan 430071, Hubei, Peoples R China
关键词
hepatocellular carcinoma; ZFPM2-AS1; genome stability; XRCC4; miR-3065-5p; DOUBLE-STRAND BREAKS; MESSENGER-RNA; DNA-REPAIR; CANCER; EXPRESSION; XRCC4;
D O I
10.3892/ijo.2022.5467
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Long noncoding RNAs (lncRNAs) have a certain link to genomic stability (GS). However, the regulatory relationship of lncRNAs and GS has not been thoroughly investigated in hepatocellular carcinoma (HCC). In the present study, samples were retrieved from The Cancer Genome Atlas with somatic mutations and lncRNA expression data. Cox regression analysis was used to identify independent prognostic factors. The RNA levels were determined by reverse transcription-quantitative PCR and protein levels were detected by western blot analysis. Cell Counting Kit-8 and colony-formation assays were used to assess cell viability. Cell migration was measured by wound-healing and Transwell assays. Cell apoptosis and cell-cycle progression were evaluated by flow cytometry. GS was detected by alkaline comet and chromosomal aberration assays. A xenograft model and lung metastasis model were used to assess the role of zinc finger protein, FOG family member 2 antisense 1 (ZFPM2-AS1) in tumor growth in vivo. The molecular mechanisms underlying the biological functions of ZFPM2-AS1 were investigated through bioinformatics prediction, RNA pull-down and luciferase reporter assays. A total of 85 genomic instability-related lncRNAs were identified and a prognostic model was developed. The prognostic model exhibited good predictive power (area under the receiver operating characteristic curve, 0.786). ZFPM2-AS1 was significantly upregulated in tumor tissues (P<0.001) and it promoted DNA damage repair (P<0.01) and tumor progression in vitro and in vivo. Luciferase reporter assays demonstrated that miR-3065-5p was able to bind directly with ZFPM2-AS1 and X-ray repair cross complementing 4 (XRCC4). ZFPM2-AS1 upregulated XRCC4 expression by acting as a sponge (P<0.001). In the present study, a prognostic model for HCC was developed and validated, and one lncRNA of its components was experimentally investigated. ZFPM2-AS1 regulates XRCC4 by sponging miR-3065-5p to promote GS and HCC progression.
引用
收藏
页数:16
相关论文
共 49 条
  • [11] LncRNA PCNAP1 modulates hepatitis B virus replication and enhances tumor growth of liver cancer
    Feng, Jinyan
    Yang, Guang
    Liu, Yunxia
    Gao, Yuen
    Zhao, Man
    Bu, Yanan
    Yuan, Hongfeng
    Yuan, Ying
    Yun, Haolin
    Sun, Mingming
    Gao, Hongwei
    Zhang, Shuqin
    Liu, Zixian
    Yin, Ming
    Song, Xijun
    Miao, Zhenchuan
    Lin, Zhongqing
    Zhang, Xiaodong
    [J]. THERANOSTICS, 2019, 9 (18): : 5227 - 5245
  • [12] RAD51-dependent recruitment of TERRA lncRNA to telomeres through R-loops
    Feretzaki, Marianna
    Pospisilova, Michaela
    Fernandes, Rita Valador
    Lunardi, Thomas
    Krejci, Lumir
    Lingner, Joachim
    [J]. NATURE, 2020, 587 (7833) : 303 - +
  • [13] Interplay of p53 and DNA-repair protein XRCC4 in tumorigenesis, genomic stability and development
    Gao, YJ
    Ferguson, DO
    Xie, W
    Manis, JP
    Sekiguchi, J
    Frank, KM
    Chaudhuri, J
    Horner, J
    DePinho, RA
    Alt, FW
    [J]. NATURE, 2000, 404 (6780) : 897 - 900
  • [14] Tumor-adjacent tissue co-expression profile analysis reveals pro-oncogenic ribosomal gene signature for prognosis of resectable hepatocellular carcinoma
    Grinchuk, Oleg V.
    Yenamandra, Surya P.
    Iyer, Ramakrishnan
    Singh, Malay
    Lee, Hwee Kuan
    Lim, Kiat Hon
    Chow, Pierce Kah-Hoe
    Kuznetsov, Vladamir A.
    [J]. MOLECULAR ONCOLOGY, 2018, 12 (01) : 89 - 113
  • [15] lncRNA SNHG6 promotes hepatocellular carcinoma progression by interacting with HNRNPL/PTBP1 to facilitate SETD7/LZTFL1 mRNA destabilization
    Haitao Wang
    Pei Ma
    Pengpeng Liu
    Deliang Guo
    Zhisu Liu
    Zhang, Zhonglin
    [J]. CANCER LETTERS, 2021, 520 : 121 - 131
  • [16] BRCA1 and RNAi factors promote repair mediated by small RNAs and PALB2-RAD52
    Hatchi, Elodie
    Goehring, Liana
    Landini, Serena
    Skourti-Stathaki, Konstantina
    DeConti, Derrick K.
    Abderazzaq, Fieda O.
    Banerjee, Priyankana
    Demers, Timothy M.
    Wang, Yaoyu E.
    Quackenbush, John
    Livingston, David M.
    [J]. NATURE, 2021, 591 (7851) : 665 - +
  • [17] Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139/GDF10 in hepatocellular carcinoma
    He, Hui
    Wang, Yawei
    Ye, Peng
    Yi, Dehui
    Cheng, Ying
    Tang, Haibo
    Zhu, Zhi
    Wang, Xun
    Jin, Shi
    [J]. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2020, 39 (01)
  • [18] F. nucleatum targets lncRNA ENO1-IT1 to promote glycolysis and oncogenesis in colorectal cancer
    Hong, Jie
    Guo, Fangfang
    Lu, Shi-Yuan
    Shen, Chaoqin
    Ma, Dan
    Zhang, Xinyu
    Xie, Yile
    Yan, Tingting
    Yu, TaChung
    Sun, Tiantian
    Qian, Yun
    Zhong, Ming
    Chen, Jinxian
    Peng, Yanshen
    Wang, Cheng
    Zhou, Xiang
    Liu, Jianjun
    Liu, Qiang
    Ma, Xiong
    Chen, Ying-Xuan
    Chen, Haoyan
    Fang, Jing-Yuan
    [J]. GUT, 2021, 70 (11) : 2123 - 2137
  • [19] TP53 mutations and hepatocellular carcinoma:: insights into the etiology and pathogenesis of liver cancer
    Hussain, S. P.
    Schwank, J.
    Staib, F.
    Wang, X. W.
    Harris, C. C.
    [J]. ONCOGENE, 2007, 26 (15) : 2166 - 2176
  • [20] Clinical significance of the expression of long non-coding RNA HOTAIR in primary hepatocellular carcinoma
    Ishibashi, Masahisa
    Kogo, Ryunosuke
    Shibata, Kohei
    Sawada, Genta
    Takahashi, Yusuke
    Kurashige, Junji
    Akiyoshi, Sayuri
    Sasaki, Shin
    Iwaya, Takeshi
    Sudo, Tomoya
    Sugimachi, Keishi
    Mimori, Koshi
    Wakabayashi, Go
    Mori, Masaki
    [J]. ONCOLOGY REPORTS, 2013, 29 (03) : 946 - 950